Sanofi, Dupixent
US private equity firm CD&R has agreed to French government demands seeking to protect jobs and investment in France. View on ...
French drugmaker Sanofi's confirmation that it will sell a controlling stake in its consumer health unit Opella to a US ...
PARIS, Oct 11 (Reuters) - Sanofi (SASY.PA), opens new tab has entered into talks ... and CD&R including guaranteeing that the business's headquarters and decision-making centres would remain ...
Sanofi said the therapies developed by the new Orano Med entity will employ ... Orano Group, which is based in Paris and maintains U.S. headquarters in Bethesda, Maryland, provides products ...
Some of the government requirements, should the deal go ahead, are likely to include the "maintenance of the headquarters ...
Paris: French drugmaker Sanofi's Monday confirmation that it plans to sell a controlling stake in its over-the-counter unit ...
In its revised bid, PAI pledged to preserve headcount and raise investments at Opella's French production sites of Lisieux in Normandy and Compiegne, the source said. It also vowed to keep Opella's ...
In the French government issued a stern warning to Clayton, Dubilier & Rice (CD&R), an American private equity firm, ...
Yen on MSN4d
Sanofi pursues sale of France's leading painkiller to US investment fund after controversyFrench pharmaceutical company Sanofi confirmed on Monday its plans to sell a controlling stake in its consumer health ...
French drugmaker Sanofi's confirmation that it will sell a controlling stake in its consumer health unit to a US investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback